Applied DNA Sciences, Inc. - Common Stock (NQ:APDN)

5.620 UNCHANGED

Last Price Updated: 4:00 PM EDT, Oct 6, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Applied DNA Sciences, Inc. - Common Stock

< Previous 1 2

...

7 8 9 10 11 12 13 14 Next >

Applied DNA to Participate in the 2022 Virtual Growth Conference Presented by Maxim Group LLC and Hosted by M-Vest on March 28th – 30th from 9:00 a.m. - 5:00 p.m. EDT

March 23, 2022

From Applied DNA Sciences, Inc.

Via Business Wire

Applied DNA Executes LOI with Spindle Biotech for Research Collaboration on Simplified High Yield mRNA Production System

March 14, 2022

From Applied DNA Sciences, Inc. and Spindle Biotech Inc.

Via Business Wire

Applied DNA Raises $4.2M Via Registered Direct Offering ↗

February 25, 2022

Applied DNA Sciences, Inc. (NASDAQ:APDN) a polymerase chai...

Via Benzinga

Applied DNA Sciences To Raise $4.2M Via Registered Direct Offering ↗

February 22, 2022

Applied DNA Sciences, Inc. (NASDAQ:APDN), a polymera...

Via Benzinga

Earnings Scheduled For February 10, 2022 ↗

February 10, 2022

Companies Reporting Before The Bell • Canada Goose Hldgs (NYSE:GOOS) is projected to report quarterly earnings at $1.46 per share on revenue of $584.49 million.

Via Benzinga

InvestorNewsBreaks — Applied DNA Sciences Inc. (NASDAQ: APDN) Closes on $4.2M Registered Direct Offering

March 11, 2022

Via Investor Brand Network

Applied DNA Announces Closing of $4.2 Million Registered Direct Offering

February 24, 2022

From Applied DNA Sciences, Inc.

Via Business Wire

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

February 22, 2022

Gainers Passage Bio (NASDAQ:PASG) shares moved upwards by 15.5% to $3.95 during Tuesday's pre-market session. The company's market cap stands at $213.3 million....

Via Benzinga

Applied DNA Announces Pricing of $4.2 Million Registered Direct Offering

February 22, 2022

From Applied DNA Sciences, Inc.

Via Business Wire

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

February 17, 2022

Gainers Creative Medical Tech (NASDAQ:CELZ

Via Benzinga

Applied DNA and EvviVax Announce Publication of Positive Preclinical Data for LinearDNA™ Platform Approach to Cancer Immunotherapy

February 17, 2022

From Applied DNA Sciences, Inc.

Via Business Wire

Looking Into Applied DNA Sciences's Return On Capital Employed ↗

February 14, 2022

Applied DNA Sciences (NASDAQ:APDN) brought in sales totaling $4.17 million during Q1 according to data provided by Benzinga Pro. However, earnings decreased 4.73%, resulting in a loss of $4.72...

Via Benzinga

78 Biggest Movers From Friday ↗

February 14, 2022

Gainers Y-mAbs Therapeutics, Inc. (NASDAQ: YMAB) surged 26% to close at $2.24. Y-mAbs reported completion of pre-BLA meeting with the FDA for Omburtamab. China Online Education...

Via Benzinga

12 Health Care Stocks Moving In Friday's After-Market Session ↗

February 11, 2022

Gainers Avenue Therapeutics (NASDAQ:ATXI...

Via Benzinga

52 Weeks High And Low Article ↗

February 11, 2022

On Friday, 106 companies reached new 52-week lows. Things to Consider About Today's 52-Week Lows: Air Products & Chemicals (NYSE:APD) is the largest company...

Via Benzinga

41 Stocks Moving In Friday's Mid-Day Session ↗

February 11, 2022

Gainers Modular Medical, Inc. (NASDAQ: MODD) shares climbed 34.5% to $4.99 following its recent uplisting to the Nasdaq Capital Market on Thursday. Kaival Brands Innovations...

Via Benzinga

Recap: Applied DNA Sciences Q1 Earnings ↗

February 10, 2022

Applied DNA Sciences (NASDAQ:APDN) reported its Q1 earnings results on Thursday, February 10, 2022 at 04:00 PM. Here's what investors need to know about the announcement.

Via Benzinga

Applied DNA First Quarter Fiscal 2022 Financial Results Feature Record Quarterly Revenues

February 10, 2022

From Applied DNA Sciences, Inc.

Via Business Wire

Applied DNA Schedules Fiscal 2022 First Quarter Financial Results Conference Call and Webcast for Thursday, February 10, 2022

February 03, 2022

From Applied DNA Sciences, Inc.

Via Business Wire

Applied DNA to Deploy Linea™ 1.0 COVID-19 Assay for Rapid Detection of New Omicron Subvariant BA.2

January 28, 2022

From Applied DNA Sciences, Inc.

Via Business Wire

Applied DNA Submits Request for Emergency Use Authorization to FDA for Linea™ 2.0 COVID-19 Assay and Linea™ Unsupervised At-Home Sample Collection Kit

January 21, 2022

From Applied DNA Sciences, Inc.

Via Business Wire

Applied DNA Announces Continued Momentum in COVID-19 Testing Demand

January 18, 2022

From Applied DNA Sciences, Inc.

Via Business Wire

Applied DNA Receives New York State Department of Health Conditional Approval for Linea™ 2.0 COVID-19 Assay as Laboratory Developed Test

January 04, 2022

From Applied DNA Sciences, Inc.

Via Business Wire

Applied DNA and Stratum Reservoir (Isotech) Sign Memorandum of Understanding to Leverage Isotopic Analysis for Enhanced DNA-Based Cotton Authenticity and Provenance

December 15, 2021

From Applied DNA Sciences, Inc.

Via Business Wire

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

December 15, 2021

Gainers Gemini Therapeutics (NASDAQ:GMTX) shares moved upwards by 32.92% to $3.23 during Wednesday's pre-market session. The market value of their outstanding shares...

Via Benzinga

12 Health Care Stocks Moving In Friday's After-Market Session ↗

December 10, 2021

Gainers Quoin Pharmaceuticals (NASDAQ:

Via Benzinga

Applied DNA Sciences Earnings Perspective: Return On Capital Employed ↗

December 10, 2021

Benzinga Pro data, Applied DNA Sciences (NASDAQ:APDN) reported Q4 sales of $3.00 million. Earnings fell to a loss of $4.51 million, resulting in a 30.78% decrease from last...

Via Benzinga

18 Stocks Moving in Friday's Pre-Market Session ↗

December 10, 2021

Gainers Context Therapeutics Inc. (NASDAQ: CNTX) rose 48.6% to $9.30 in pre-market trading as the company announced data from ONA-XR in early breast cancer. The company said ONA-...

Via Benzinga

The Daily Biotech Pulse: Lilly Sings Metabolic Disorder Drug Pact, Moderna Reports Positive Flu Vaccine Data, Halozyme To Buy Back Shares ↗

December 10, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Angion Biomedica's ANG-3777 Does Not Meet Primary Endpoint In Mid-Stage...

Via Benzinga

Applied DNA Sciences' Q4 Revenues Skyrockets Buoyed By Momentum In COVID-19 Diagnostic Testing ↗

December 10, 2021

Applied DNA Sciences Inc (NASDAQ: APDN) reported a more than ninefold Y/Y increase in Q4 FY21 revenues, driven by the rise in clinical laboratory service revenues related to...

Via Benzinga

< Previous 1 2

...

7 8 9 10 11 12 13 14 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.